Coramaze Technologies develops the Tripair, a device repairing functional Tricuspid Regurgitation (fTR) in heart failure patients, to improve quality of life and reduce morbidity. The Tripair implant is anchored a-traumatically in the right atrium, enabling full retrievability and intra-procedural efficacy evaluation.
View Top Employees from Coramaze Technologies| Website | http://www.coramaze.com |
| Revenue | $4 million |
| Employees | 17 (11 on RocketReach) |
| Founded | 2013 |
| Phone | +49 491 795570001 |
| Technologies |
JavaScript,
HTML,
PHP
+16 more
(view full list)
|
| Industry | Medical Equipment Manufacturing, Manufacturing General, Biotechnology, Medical devices, Manufacturing, Science and Engineering, Cardiovascular medical technology, Health Care, Transcatheter Mitral Valve Repair, Medical, Structural heart valve diseases, Medical Device |
| SIC | SIC Code 38 Companies, SIC Code 384 Companies |
| NAICS | NAICS Code 33 Companies, NAICS Code 339 Companies |
Looking for a particular Coramaze Technologies employee's phone or email?
Coramaze Technologies Questions
The Coramaze Technologies annual revenue was $4 million in 2023.
Till Neumann is the Chief Medical Officer of Coramaze Technologies.
11 people are employed at Coramaze Technologies.
The NAICS codes for Coramaze Technologies are [33, 339].
The SIC codes for Coramaze Technologies are [38, 384].
Top Coramaze Technologies Employees
-
1
-
3
-
1
-
View
Vadim Gordon
Senior Research And Development Technician at Coramaze Technologies
Tel Aviv District, Israel
Related Companies
